AI firm Ketryx raises $39M, adds former Medtronic CEO as investor

As the Food and Drug Administration regulates a growing number of software and AI tools, the agency is also clarifying regulatory requirements. For example, the FDA has opened a pathway for pre-determined changes to medical devices — which could be useful for updates to AI models — but the process requires upfront documentation.

Ketryx’s platform is intended to help automate software documentation.